Search research articles
Contact Us
Filters
Showing results (21-30 of 134) with videos related to
Page
of 14
Sort By:
Journal of Medical Virology
|
December 24, 2025
Development of a Next-Generation Sequencing Protocol for Assessing Lenacapavir Resistance in HIV-1 Capsid
Omar El Khalili, Collins Ambe Chenwi, Daniele Spalletta, et al.
HIV Medicine
|
January 22, 2021
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice
Daniele Armenia, Yagai Bouba, Roberta Gagliardini, et al.
Viruses
|
April 26, 2025
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status
Greta Marchegiani, Luca Carioti, Luigi Coppola, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
May 5, 2022
Evaluation of HIV-1 integrase variability by combining computational and probabilistic approaches
Davide Vergni, Daniele Santoni, Yagai Bouba, et al.
AIDS Research and Human Retroviruses
|
June 12, 2008
The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries
Marco Salemi, Maureen M Goodenow, Stefania Montieri, et al.
International Journal of Antimicrobial Agents
|
December 6, 2021
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV
Daniele Armenia, Maria Mercedes Santoro, Maria Concetta Bellocchi, et al.
BMC Pediatrics
|
July 7, 2019
Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)
Joseph Fokam, Maria Mercedes Santoro, Desire Takou, et al.
Current HIV Research
|
October 1, 2015
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians
Romina Salpini, Joseph Fokam, Laura Ceccarelli, et al.
Molecules (Basel, Switzerland)
|
November 11, 2022
Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach
Isabella Romeo, Francesca Alessandra Ambrosio, Giosuè Costa, et al.
The Journal of Antimicrobial Chemotherapy
|
July 22, 2025
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era
Rebecka Papaioannu Borjesson, Sara Diotallevi, Riccardo Lolatto, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 134) with videos related to
Sort By:
Page
of 14
Journal of Medical Virology
|
December 24, 2025
Development of a Next-Generation Sequencing Protocol for Assessing Lenacapavir Resistance in HIV-1 Capsid
Omar El Khalili, Collins Ambe Chenwi, Daniele Spalletta, et al.
HIV Medicine
|
January 22, 2021
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice
Daniele Armenia, Yagai Bouba, Roberta Gagliardini, et al.
Viruses
|
April 26, 2025
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status
Greta Marchegiani, Luca Carioti, Luigi Coppola, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
May 5, 2022
Evaluation of HIV-1 integrase variability by combining computational and probabilistic approaches
Davide Vergni, Daniele Santoni, Yagai Bouba, et al.
AIDS Research and Human Retroviruses
|
June 12, 2008
The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries
Marco Salemi, Maureen M Goodenow, Stefania Montieri, et al.
International Journal of Antimicrobial Agents
|
December 6, 2021
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV
Daniele Armenia, Maria Mercedes Santoro, Maria Concetta Bellocchi, et al.
BMC Pediatrics
|
July 7, 2019
Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)
Joseph Fokam, Maria Mercedes Santoro, Desire Takou, et al.
Current HIV Research
|
October 1, 2015
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians
Romina Salpini, Joseph Fokam, Laura Ceccarelli, et al.
Molecules (Basel, Switzerland)
|
November 11, 2022
Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach
Isabella Romeo, Francesca Alessandra Ambrosio, Giosuè Costa, et al.
The Journal of Antimicrobial Chemotherapy
|
July 22, 2025
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era
Rebecka Papaioannu Borjesson, Sara Diotallevi, Riccardo Lolatto, et al.
Page
of 14